Yejin Kim

Uncertainty-aware multimodal biomarker-guided treatment response prediction in metastatic NSCLC remains a critical unmet need to support robust therapy selection and adaptation over time. We developed a multimodal framework integrating FDG-PET, T-cell recepto...

Early body composition (BC) loss after chemotherapy associates with poor outcomes in PDAC, but its implications for treatment strategy remain unclear. Radiotherapy (RT) is sometimes considered after 6 months of chemotherapy for patients with unresectable dise...

Patients receiving radiotherapy (RT) for liver cancer have limited liver function reserves, which increases risk of radiation-induced liver injury, but tools to evaluate functional response post-RT are lacking. We modeled liver function changes on 99mTc sulfu...